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B lymphocytes and Raji cells express the complement receptor type 2 (CR2) of 145 kDa which recognises 
the C3d fragment of C3. When intact cells are treated with trypsin, CR2 is degraded. There is a parallel 
loss in C3d-mediated rosetting and in proteins which bind to CSd-Sepharose. Initially 97 and then 83 kDa 
fragments of CR2 are produced which retain C3d binding activity. These fragments are associated with the 
cell surface and mediate rosetting. Purified lzsI-lahelled CR2, solubilised in detergent, produces fragments 
of apparently identical size on treatment with trypsin. The 83 kDa fragment produced by trypsin treatment 
closely resembles the major C3d binding protein spontaneously released into Raji cell culture medium. 
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1. INTRODUCTION 
The third component of the complement, C3, 
binds covalently to surfaces which activate the 
complement system, as the C3b fragment (Z% 
178000) [l]. This fragment acts as a component of 
the complex enzymes, C3 convertase and CS con- 
vertase, which activate C3 and CS, respectively, in 
the complement sequence. C3b is inactivated by 
cleavage to iC3b (M 175000) [2]. Subsequently 
iC3b is degraded to C3d,g (Mr 38000) and C3d (Mr 
33000) [3]. These fragments of C3 are recognised 
by cell surface receptors which mediate 
phagocytosis [4] and are possibly involved in con- 
trol of the immune response [5]. 
Human B-lymphocytes rosette with particles 
coated with C3b, iC3b or C3d. The C3b-rosetting 
activity is due to a 250 kDa membrane glycopro- 
tein [6] termed complement receptor type 1 (CRl) 
[7], also present on human erythrocytes, polymor- 
phonuclear leucocytes and monocytes. 
* To whom correspondence should be addressed 
The C3d binding activity (CR2) [7] is due to a 
protein of 145 kDa [8], identical to the B lym- 
phocyte differentiation antigen recognised by the 
monoclonal antibody B2 [8,9]. Rosetting with 
iC3b coated cells is mediated by both CR1 and 
CR2, each of which has an affinity for iC3b [lo]. 
Although the molecules on tonsil B lymphocytes 
which mediate rosetting with C3 fragments have 
been identified, the situation with Raji and other 
lymphoblastoid cells is less clear. Raji cells rosette 
with C3b-coated particles although they do not ex- 
press the CR1 protein [l 11. It has been suggested 
that C3b-binding activity is due to a 140 kDa pro- 
tein [ 121 or to a Factor H-like molecule (150 kDa) 
[ 131. The protein responsible for the C3d-binding 
activity of Raji cells was initially identified as a 
72 kDa protein prepared from the supernatants of 
Raji cell cultures [ 141. Antigenic cross-reactivity 
has been observed between the 72 kDa protein and 
the Epstein-Barr virus (EBV) receptor [ 151. 
Reports that the 145 kDa CR2 is the EBV receptor 
[16] and that antibodies to the 72 kDa protein in- 
hibit CR2 activity [17] strengthen earlier sugges- 
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tions [S, 181 that the 72 kDa molecule is a fragment 
of CR2. 
This report describes the proteolytic fragmenta- 
tion of CR2, from B lymphocytes and Raji cells, 
both on the cell surface and solubilised in non- 
ionic detergent. The C3d-binding fragments have 
been compared with the C3d binding proteins from 
Raji culture medium. The relationship between 
CR2 and the molecule from the culture medium is 
discussed. 
2. MATERIALS AND METHODS 
2.1. Cells 
Raji cells (Flow Laboratories, Irvine, Ayrshire, 
England) were cultured in RPM1 1640 supple- 
mented with 10% (v/v) foetal calf serum, penicillin 
(100 IU/ml) and streptomycin (100 pg/ml). Spent 
medium was collected when the cells had grown to 
approx. 106/ml. 
Biosynthetically labelled Raji cell products were 
prepared from cells cultured in RPM1 1640 
without methionine (Flow Laboratories) sup- 
plemented with 5Yo (v/v) foetal calf serum, 
penicillin and streptomycin in the presence of 
10 &i/ml [35S]methionine (Amersham Interna- 
tional, Amersham) for 3 days. 
B lymphocytes were prepared from human ton- 
sils obtained from routine tonsillectomy [lo]. 
Cells were surface-radioiodinated by incubating 
a suspension (5 x lo6 cells) in 0.5 ml PBS (8.2 mM 
Na2HP04, 1.5 mM KH2P04, 139 mM NaCI, 
3 mM KCl, 1 mM CaC12, 1 mM MgC12, pH 7.2) 
with 0.5 mCi 1251 (Amersham) in polyethylene 
tubes coated with Iodogen (Pierce and Warriner, 
Chester, England) for 10 min at room tempera- 
ture. The cells were washed 4 times in PBS at room 
temperature to remove free iodide. 
Cells were suspended at 2 x lO’/ml in DGVB2+ 
(140 mM glucose, 71 mM NaCl, 2.5 mM sodium 
barbitone, 0.5 mM MgC12, 0.15 mM CaC12, pH 
7.5 containing 0.1% gelatin) and treated with tryp- 
sin (TPCK-treated, Worthington, Freehold, NJ) at 
lOOpg/ml at 37°C. Samples were removed at the 
times indicated and proteolysis stopped by addi- 
tion of soy bean trypsin inhibitor (Type lS, Sigma, 
Poole, England) at a 3-fold weight excess over 




Sheep erythrocytes coated with IgM, Cl and C4 
(EAC14) and with C3d (EAC3d) were made and 
rosette measurements were performed as before 
[lo]. Rosetting was measured by incubating lo6 
trypsin-treated Raji cells with 10’ EAC14 or 
EAC3d cells for 20 min at 37°C. Rosetting was 
estimated by microscopic examination. The roset- 
ting of EAC14 was insignificant in all cases. 
2.3. Affinity chromatography 
Radioiodinated or biosynthetically labelled cells 
(2 x lO’/ml) were lysed by addition of an equal 
volume of lysing buffer (2070, w/v) Nonidet-P40 
(NP4C$ Sigma), 10 mM sodium phosphate, pH 
7.4, containing lO/lg/ml soy bean trypsin in- 
hibitor, 5 mM iodoacetamide and 2 mM phenyl- 
methylsulphonyl fluoride (PMSF), and mixed on 
ice for 20 min. The extract was centrifuged (50000 
x g for 10 min) and applied to a C3d-Sepharose 
column [lo] (1 ml containing 2.2 mg C3d/ml 
Sepharose) equilibrated with 1% (w/v) NP40 in 
10 mM sodium phosphate buffer, pH 7.4, at 
6 ml/h. The column was washed in the same buff- 
er and the C3d-binding proteins were eluted with a 
linear NaCl gradient (total volume 40 ml) up to 
500 mM NaCl in the starting buffer. The method 
used is similar to that described [lo]. 
2.4. SDS-polyacrylamide gel electrophoresis 
Samples for SDS-polyacrylamide gel elec- 
trophoresis (SDS-PAGE) were prepared by 
precipitation with 10% (w/v) trichloroacetic acid 
at 5”C, using 5Opg soy bean trypsin inhibitor as 
carrier protein. The precipitate was washed once 
with 5% (w/v) trichloroacetic acid and twice with 
ice-cold acetone before solubilization in 1% (w/v) 
SDS, 4 M urea, 100 mM Tris-HCl, pH 8, at 80°C 
for 10 min. Samples were reduced with 3 mg/ml 
dithiothreitol and alkylated with 16 mg/ml 
iodoacetamide. SDS-PAGE was performed ac- 
cording to Laemmli [19] using a 6.5% gel. Marker 
proteins were visualised by Coomassie blue stain- 
ing and the gels were dried for autoradiography us- 
ing Fuji RX film and a Cronex ‘lightning plus’ in- 
tensifying screen (DuPont, Stevenage, Herts, 
England) exposed at - 70°C. 
2.5. Preparation of radiolabelled CR2 
‘251-labelled CR2 was prepared from human 
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spleen. Spleen membranes, a gift from Dr S.-K. 
Law, were prepared by homogenising chopped 
spleen suspended in 2.5% (w/v) Tween 40 (Sigma), 
10 mM Tris-HCl, pH 8, containing 10 mM 
iodoacetamide, 2.5 mM di-iodopropyl phosphoro- 
fluoridate (Sigma) and 0.2 mM PMSF with a Pot- 
ter homogeniser (6 strokes, 100 rpm) on ice. This 
material was centrifuged at 3000 x g for 15 min 
and the supernatant centrifuged at 40000 x g for 
20 min. The pellet produced was washed twice in 
10 mM Tris-HCl, pH 7.4, and resuspended at a 
protein concentration of 20 mg/ml in lysing buf- 
fer. This preparation was mixed with a solubilised 
extract of 2 x lo7 surface-radioiodinated Raji cells 
in the same buffer. The mixture was applied to a 
C3d-Sepharose column (5 ml), as described in sec- 
tion 2.3. The bound material was eluted with a gra- 
dient to 500 mM NaCl (total volume 100 ml) in 
10 mM sodium phosphate, 1% (w/v) NP40, pH 
7.4. The fractions were analysed by SDS-PAGE 
and autoradiography and the CR2-containing frac- 
tions were pooled. The pooled material was 
reiodinated using 1 mCi Nalz51 in the presence of 
one Iodobead (Pierce and Warriner) for 10 min on 
ice. Free iodide was removed by gel filtration on a 
Sephadex G25 column, equilibrated in 1% (w/v) 
NP40, 10 mM sodium phosphate, pH 7.4. The 
preparation was further purified by a second 
passage and elution from a C3d-Sepharose column 
as described above. 
2.6. Purification and Iabelling of proteins from 
spent medium 
Raji cells (106/ml) in culture medium (250 ml) 
were centrifuged at 1000 x g for 5 min and the 
culture supernatant was then centrifuged at 100000 
x g for 1 h. The 100000 x g pellet was solubilized 
in lysing buffer for 20 min on ice. The solubilized 
extract of the 100000 x g pellet was applied to a 
C3d-Sepharose column (1 ml) as described above. 
The C3d-binding proteins were eluted with 5 ml of 
100 mM NaCl, 1% (w/v) NP40, 10 mM sodium 
phosphate, pH 7.4 and labelled with 0.5 mCi 
Na’251, using one Iodobead. Free iodide was 
removed by gel filtration as above (section 2.5), 
and repurified on C3d-Sepharose as before. 
The 100000 x g supernatant of Raji cell medium 
was dialysed against 10 mM sodium phosphate, 
pH 7.4, and run on a C3d-Sepharose column 
(5 ml) as described in section 2.5, but without 
detergent (NP40). The C3d-binding proteins were 
eluted with 25 ml of 100 mM NaCl in 10 mM 
phosphate (pH 7.4) and labelled with 1251. The 
iodinated proteins were then repurified on C3d- 
Sepharose in the absence of detergent. 
Medium from cells cultured in the presence of 
[35S]methionine was centrifuged as above. The 
detergent extract of the 100000 x g pellet was ap- 
plied to a C3d-Sepharose column and the eluted 
proteins were analysed by SDS-PAGE. The gel was 
impregnated with Autofluor (National Diagnos- 
tics, Aston Clinton, Bucks, England) prior to dry- 
ing down and autofluorography at -70°C. 
3. RESULTS 
3.1. Trypsinization of cells 
To establish whether active fragments of CR2 
could be produced, B lymphocytes or cultured Raji 
cells were treated with trypsin and the degradation 
of CR2 was measured. 
Surface 1251-labelled Raji cells were trypsinized 
as described in section 2.1 and a small sample of 
the cells was assessed for rosetting to EAC3d at 
each time point. Fig. 1 shows the progressive loss of 
0 16 
Fig.1. Loss of rosetting with EAC3d cells and loss of 
C3d-binding proteins during trypsin treatment. 
Rosetting is expressed as the average number of 
erythrocytes per Raji cell (+) (100 Raji cells were 
counted). 1251-labelled Raji cells were treated with 
trypsin, solubilised, and extracts applied to a C3d- 
Sepharose column in 1% (w/v) NP40, 10 mM sodium 
phosphate, pH 7.4. Bound proteins were eluted as 
described in section 2.3. The radioactivity associated 
with bound proteins is shown (+). 
197 
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rosetting activity during trypsin treatment. Cell 
pellets at each time point were solubilized with lys- 
ing buffer and extracts were applied to C3d- 
Sepharose columns. The columns were washed and 
the C3d-binding proteins were eluted by increasing 
the ionic strength as described in section 2.3. The 
radioactivity in the C3d-binding proteins is shown 
in fig. 1. It can be seen that the loss of the 1251 
radioactivity bound to C3d-Sepharose closely 
follows the loss of rosetting. 
The C3d-Sepharose column eluates were 
precipitated with trichloroacetic acid and analysed 
by SDS-PAGE. Fig.2a shows an autoradiograph 
of the gel tracks corresponding to 0, 4 and 16 min 
of trypsin treatment. It can be seen that CR2 of 
145 kDa in track 1 is broken down in 4 min to 2 
major fragments of 97 kDa and 83 kDa which still 
bind C3d. By 16 min only a small amount of the 
83 kDa fragment remains. 
The sections of the gel containing the 145, 97 
and 83 kDa bands were cut out and the radioactivi- 
ty measured. The counts are shown in fig.2b. The 
97 kDa species appears transiently in the early 
stages of trypsin treatment. The 83 kDa species ap- 
pears after the 97 kDa protein and persists longer. 
After 4 min the predominant C3d binding species 
is the 83 kDa molecule which appears to mediate a 
reduced but significant level of rosetting (cf. fig. 1). 
Rosetting has dropped to half its original value 
after 4 min of treatment with trypsin although less 
than 10% of the intact CR2 remains. Because of 
the purification procedure, the proteins visible on 
the autoradiograph are cell-surface-associated 
C3d-binding proteins and, as such, are likely to 
mediate EAC3d rosetting. 
Similar results have been obtained from surface 
labelled tonsil B lymphocytes. 
3.2. Trypsinization of solubilized CR2 
Trypsin treatment of 1251-labelled, solubilized 
CR2 from spleen results in breakdown of the 
145 kDa CR2 with sequential appearance of the 97 
and 83 kDa fragment (fig.3). Breakdown of the 
83 kDa fragment is slow under the conditions 
used. By 8 min it is the major fragment visible, and 
incubation for up to 2 h does not result in further 
breakdown. 
Digests of solubilized CR2 from spleen were 
subjected to C3d-Sepharose chromatography (sec- 
tion 2.3) to determine which fragments retain the 
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Fig.2. Analysis of C3d-binding proteins following 
trypsin treatment of Raji cells. (a) Autoradiographs of 
polyacrylamide g l tracks of C3d-binding proteins from 
1251-labelled Raji cells following trypsinization for the 
indicated times. Positions of CR2 and its fragments are 
shown by arrows. Positions of M, standards rv2M (MI 
167000), phosphorylase (Mr 92000) and catalase (MI 
60000) are indicated. (b) Distribution of radioactivity 
between different C3d-binding proteins following 
trypsinization. (--o--) Intact CR2, MI 145000; (-+-) 
M, 97000; (-A---) M, 83000. Radioactivity isexpressed 
as a percentage of the radioactivity in the CR2 band 
before trypsinization. 
C3d binding activity. Intact CR2 purified in this 
way rebinds to C3d-Sepharose and runs at an ap- 
parent M, of 130000 on SDS-PAGE in non- 
reducing conditions. The 83 kDa fragment also 
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Fig.3. Trypsinization of detergent-solubilized CR2. 
Autoradiograph of a polyacrylamide gel of ‘251-labeIled 
CR2 treated with trypsin (IO pg/ml in 1% NP40, 0.1% 
gelatin, 10 mM sodium phosphate, pH 7.4, containing 
0.5 mM MgClz and 0.15 mM CaC12) for the times 
indicated as described in section 2. CR2 and the 
molecular masses of the radioactive bands are shown, 
calculated from standards as in the legend to fig.2a. 
binds to C3d-Sepharose (fig.4, track 3). This frag- 
ment runs at 65 kDa in non-reducing conditions 
and is not apparently disulphide-linked to any 
other major fragment. 
medium 
Spent Raji cuiture medium was centrifuged at 
1~~ x g to produce a pehet fraction including 
membranous debris which was subsequently ex- 
tracted with detergent, and a supernatant of solu- 
ble proteins. These 2 fractions were subjected to 
affinity chromatography to identify C3d-binding 
proteins. These preparations were labelied with 




Fig.4. Comparison of C3d-binding proteins from spent 
Raji culture medium and from tryptic digest of purified 
CR2. Autoradiographs of po~ya~rylamide g ls of “‘I- 
labelled C3d-binding proteins prepared from spent 
culture medium (track I); [35S]methionine labelled C3d- 
binding proteins from spent culture medium (track 2) 
and ‘251-labelIed C3d-binding tryptic fragments of 
purified CR2 (track 3). Samples were prepared as 
discussed in the text. 
When anafysed on SDS-PAGE (fig.4), the 
100000 x g pellet preparation shows bands at 145, 
120,83 and 45 kDa (track 1). Greater than 9OVo of 
the radioactivity is in the 83 kDa band. The 
1~~ x g supernatant showed no recognisable 
bands (not shown). The prominent 83 kDa band 
has the same Rf as the principal fragment from 
partial trypsinization of CR2 (fig.4, track 3). No 
C3d-binding proteins are present in unused culture 
medium processed in the same way. 
To determine whether these C3d binding pro- 
teins were synthesized by the cells, Raji cells were 
cultured in the presence of [3sS]methionine. The 
medium from such cultures was fractionated into 
100000 x g pellet and supernatant and both 
199 
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analysed for C3d-binding proteins as before. A 
similar labelled 83 kDa protein is found in the 
medium pellet preparation (fig.4, track 2), in- 
dicating that this protein is produced by the cells. 
For comparison C3d-binding proteins in a tryptic 
digest of 1251-labelled CR2 is shown (fig.4, track 
3). 
4. DISCUSSION 
Tonsil B lymphocytes and Raji cells both express 
CR2 molecules which are indistinguishable from 
each other on SDS-PAGE analysis and are the 
same as the CR2 prepared from whole spleen. This 
is in contrast to CR1 which exhibits a change in ap- 
parent size when expressed in different cell types 
WI. 
Raji cell rosetting with EAC3d is sensitive to 
trypsin treatment, and the loss of 1251-labelled pro- 
teins which bind to a C3d affinity column exactly 
follows the loss of rosetting (fig. 1). The loss of the 
intact 145 kDa CR2 molecule is more rapid than 
the loss of rosetting activity indicating that the re- 
maining C3d-binding proteins, principally the 
83 kDa fragment, can mediate rosetting (fig.2). 
This fragment can be produced by trypsin treat- 
ment of whole cells or by trypsin treatment of af- 
finity purified CR2 in non-ionic detergent (fig.3). 
It was reported that a C3d-binding molecule of 
approx. 72 kDa could be isolated from spent Raji 
cell culture medium [ 111. To determine whether in- 
tact CR2 or an active fragment of CR2 was re- 
leased, spent culture medium was examined for 
proteins which would bind to C3d-Sepharose. Par- 
ticulate and soluble material was separated by cen- 
trifugation at 100000 x g for 1 h. The supernatant 
contained no C3d-binding proteins. A detergent 
extract of the particulate pellet contained traces of 
intact 145 kDa CR2 (fig.4) together with a major 
83 kDa C3d-binding protein. This molecule 
migrates identically on SDS-PAGE to the 83 kDa 
tryptic fragment of CR2 (fig.4). These results in- 
dicate that CR2 fragments which recognise C3d are 
released into Raji culture medium possibly in a 
form associated with membranous vesicles. 
Although no direct comparison of the 72 kDa 
molecule previously reported [14] and the 83 kDa 
fragment reported here is possible, these species 
have very similar characteristics, and are likely to 
be the same. Some variation in molecular mass as 
200 
estimated by SDS-PAGE is not unexpected, as the 
72 kDa fragment is glycosylated [8]. If these 
fragments are closely related then the speculation 
[8,17,18] that the first-reported 72 kDa protein is 
a fragment of CR2 is confirmed. 
The characteristics of the 83 kDa fragment 
reported here are consistent with it being mem- 
brane bound as it is not released from trypsin- 
treated cells, and it can be sedimented from spent 
culture medium and subsequently solubilised by 
detergent. Similarly sized fragments of CR2 have 
been reported after V8 protease treatment of Raji 
cells [21]. The production of distinct stable pro- 
teolytic fragments of CR2 may be useful in subse- 
quent structural analysis as the C3 binding site ap- 
pears 10 be preserved. 
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